Literature DB >> 12005540

Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines.

P F J W Rijken1, J P W Peters, A J Van der Kogel.   

Abstract

Tissue oxygenation influences the radiation response of tumors. To further investigate the underlying mechanisms of tumor hypoxia, the spatial distribution of hypoxic cells in relation to the vasculature was studied. In a panel of three human glioma xenograft lines (E2, E102, E106) with different growth characteristics, tumor line-specific patterns of hypoxia (pimonidazole) and (functional) vasculature (Hoechst 33342) were observed. Two of the three glioma lines showed a more homogeneous distribution of perfused vessels (E102 and E106) than the third glioma line (E2). Although all tumors showed hypoxia, the distance at which the steepest part of the gradient of the hypoxia marker was found varied significantly among the different glioma lines. The faster-growing E102 tumors had the longest distance (>300 microm). These results indicate that tumor line-specific factors, rather than vascular geometry alone, may determine the oxygenation status of a tumor. As a consequence, vascular density cannot be used as a surrogate parameter for tumor hypoxia when comparing different tumors. Additional hypoxia and perfusion markers will further improve our understanding of changes in tumor physiology at the microregional level explaining the relationship between the low oxygen levels and the response of tumors to treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005540     DOI: 10.1667/0033-7587(2002)157[0626:qaovpo]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Authors:  Tim J Kruser; Deric L Wheeler; Eric A Armstrong; Mari Iida; Kevin R Kozak; Albert J van der Kogel; Johan Bussink; Angela Coxon; Anthony Polverino; Paul M Harari
Journal:  Clin Cancer Res       Date:  2010-05-27       Impact factor: 12.531

2.  Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response.

Authors:  Twan van den Beucken; Marianne Koritzinsky; Hanneke Niessen; Ludwig Dubois; Kim Savelkouls; Hilda Mujcic; Barry Jutten; Juraj Kopacek; Sylvia Pastorekova; Albert J van der Kogel; Philippe Lambin; Willem Voncken; Kasper M A Rouschop; Bradly G Wouters
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

3.  An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of concept.

Authors:  Marian Axente; Jun He; Christopher P Bass; Gobalakrishnan Sundaresan; Jamal Zweit; Jeffrey F Williamson; Andrei Pugachev
Journal:  Radiother Oncol       Date:  2014-01-30       Impact factor: 6.280

4.  Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.

Authors:  Sydney M Evans; Kevin W Jenkins; W Timothy Jenkins; Thomas Dilling; Kevin D Judy; Amy Schrlau; Alexander Judkins; Stephen M Hahn; Cameron J Koch
Journal:  Radiat Res       Date:  2008-12       Impact factor: 2.841

5.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5.

Authors:  Kasper M A Rouschop; Twan van den Beucken; Ludwig Dubois; Hanneke Niessen; Johan Bussink; Kim Savelkouls; Tom Keulers; Hilda Mujcic; Willy Landuyt; Jan Willem Voncken; Philippe Lambin; Albert J van der Kogel; Marianne Koritzinsky; Bradly G Wouters
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

6.  Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo.

Authors:  Helena C Besse; Angelique D Barten-van Rijbroek; Kim M G van der Wurff-Jacobs; Clemens Bos; Chrit T W Moonen; Roel Deckers
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.